Table 4 Antimicrobial resistance pattern of the 83 S. pneumoniae isolates
Resistance pattern | Total (n = 83) | Asymptomatic carriers (n = 52) | CAP carriers (n = 31) | ||
|---|---|---|---|---|---|
n (%) | n (%) | Serotype (n) | n (%) | Serotype (n) | |
ERY-CLI | 8 (9.6) | 6 (11.5) | 6 (2), 3 (2), 35 (1), untyped (1) | 2 (6.5) | 3 (1), 6 (1) |
ERY-CLI-SXT | 4 (4.8) | 3 (5.8) | 34 (1), 22 (1), 35 (1) | 1 (3.2) | 23F (1) |
ERY-CLI-TET | 10 (12.0) | 3 (5.8) | 3 (2),6 (1) | 7 (22.6) | 3 (2), 4 (1), 14 (1), 23F (1), 23A (1), 35 (1) |
ERY-CLI-CXM | 2 (2.4) | 2 (3.8) | 6 (1), untyped (1) | 0 (0.0) | – |
ERY-CLI-MER | 1 (1.2) | 1 (1.9) | 3 (1) | 0 (0.0) | – |
ERY-CLI-LIN | 1 (1.2) | 1 (1.9) | 6 (1) | 0 (0.0) | – |
ERY-CLI-SXT-TET | 21 (25.3) | 18 (34.6) | 3 (4), 23A (3), 6 (2), 18 (2), 35 (2), 23B (1), 11 (1), untyped (3) | 3 (9.7) | 8 (2),19F (1) |
ERY-CLI-TET-CEF | 1 (1.2) | 1 (1.9) | 6 (1) | 0 (0.0) | – |
ERY-CLI-SXT-CEF | 1 (1.2) | 1 (1.9) | 35 (1) | 0 (0.0) | – |
ERY-CLI-TET-CXM-CEF | 1 (1.2) | 1 (1.9) | 16F (1) | 0 (0.0) | – |
ERY-CLI-SXT-TET-CEF | 1 (1.2) | 1 (1.9) | 19F (1) | 0 (0.0) | – |
ERY-CLI-SXT-TET-CXM | 11 (13.3) | 6 (11.5) | 15 (2), 34 (1), 13 (1), 3 (1), 6 (1) | 5 (16.1) | 3 (2),19F (1), 23F (1), 23A (1) |
ERY-CLI-SXT-TET-CXM-PEN | 8 (9.6) | 3 (5.8) | 19A (2), 23F (1) | 5 (16.1) | 19A (3), 19F (2) |
ERY-CLI-SXT-TET-CXM-CEF-PEN | 7 (8.4) | 3 (5.8) | 19F (2), 3 (1) | 4 (12.9) | 3 (2), 19F (2) |
ERY-CLI-SXT-TET-CXM-CEF-PEN-LIN | 1 (1.2) | 1 (1.9) | 19F (1) | 0 (0.0) | – |
ERY-CLI-SXT-TET-CXM-CHL-PEN-CEF-PEN | 1 (1.2) | 1 (1.9) | 3 (1) | 0 (0.0) | – |
ERY-CLI-SXT-TET-PEN-VAN-RIF-LIN | 1 (1.2) | 0 (0.0) | – | 1 (3.2) | 3 (1) |
ERY-CLI-SXT-CXM-CEF-PEN-CRO-CFP | 1 (1.2) | 0 (0.0) | – | 1 (3.2) | 20 (1) |
ERY-CLI-SXT-TET-CXM-CHL-CEF-PEN | 1 (1.2) | 0 (0.0) | – | 1 (3.2) | 19F (1) |
ERY-CLI-SXT-TET-CXM-CHL-PEN-VAN-RIF-LIN | 1 (1.2) | 0 (0.0) | – | 1 (3.2) | 3 (1) |